International Biotechnology (LON:IBT) Shares Pass Above 200-Day Moving Average - What's Next?

Key Points

• International Biotechnology (LON:IBT) shares have crossed above their 200-day moving average, indicating a potential positive trend as the stock traded as high as GBX 780 ($10.49).
• The company's current market capitalization stands at £260.85 million with a significantly high P/E ratio of 1,601.16.
• International Biotechnology aims for long-term capital growth by investing in a diversified portfolio of biotechnology and life sciences companies with strong growth prospects.

International Biotechnology (LON:IBT - ) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 623.55 ($8.38) and traded as high as GBX 780 ($10.49). International Biotechnology shares last traded at GBX 774 ($10.40), with a volume of 55,913 shares trading hands.

International Biotechnology Trading Down 0.5%

The stock has a market capitalization of £260.85 million, a P/E ratio of 1,601.16 and a beta of 0.21. The stock's fifty day moving average price is GBX 683.76 and its two-hundred day moving average price is GBX 623.55.

About International Biotechnology

The Company's investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.